Kerala Ayurveda Ltd Stock Price Today (NSE: KERALAYUR)
Fundamental Score
Kerala Ayurveda Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Kerala Ayurveda Ltd share price today is ₹179.15, down 4.61% on NSE/BSE as of 18 June 2026. Kerala Ayurveda Ltd (KERALAYUR) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹437.96 (Cr). The 52-week high for KERALAYUR share price is ₹625.00 and the 52-week low is ₹150.00. The company has a Return on Equity (ROE) of -99.22% and a debt-to-equity ratio of 15.49.
Kerala Ayurveda Ltd Share Price Chart — NSE/BSE Historical Performance
Kerala Ayurveda Ltd share price chart: -11.57% return over the past month. 52-week high ₹625.00, 52-week low ₹150.00.
Kerala Ayurveda Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹187.80 | ₹192.95 | ₹178.45 | ₹179.15 | 14.58K (Cr) | |
| ₹199.90 | ₹199.90 | ₹184.50 | ₹187.80 | 8.98K (Cr) | |
| ₹200.20 | ₹203.40 | ₹193.25 | ₹194.15 | 25.67K (Cr) | |
| ₹200.15 | ₹212.95 | ₹200.15 | ₹203.40 | 9.63K (Cr) | |
| ₹211.70 | ₹218.10 | ₹205.00 | ₹206.50 | 8.80K (Cr) | |
| ₹212.05 | ₹214.40 | ₹208.50 | ₹211.70 | 3.07K (Cr) | |
| ₹214.95 | ₹214.95 | ₹205.60 | ₹211.25 | 3.21K (Cr) | |
| ₹202.00 | ₹209.65 | ₹202.00 | ₹209.30 | 3.31K (Cr) | |
| ₹196.55 | ₹206.25 | ₹196.55 | ₹199.70 | 4.57K (Cr) | |
| ₹204.95 | ₹208.60 | ₹202.55 | ₹204.95 | 2.52K (Cr) |
Kerala Ayurveda Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹199.90 | ₹199.90 | ₹178.45 | ₹179.15 | -10.38% | |
| ₹219.30 | ₹243.00 | ₹193.25 | ₹194.15 | -11.47% | |
| ₹161.80 | ₹257.00 | ₹161.80 | ₹216.65 | +33.90% | |
| ₹200.00 | ₹228.00 | ₹150.00 | ₹157.75 | -21.13% | |
| ₹240.30 | ₹260.10 | ₹196.15 | ₹205.65 | -14.42% | |
| ₹310.55 | ₹340.00 | ₹246.00 | ₹258.30 | -16.82% | |
| ₹369.95 | ₹378.00 | ₹301.35 | ₹315.75 | -14.65% | |
| ₹430.15 | ₹430.15 | ₹333.05 | ₹366.20 | -14.87% | |
| ₹475.00 | ₹484.90 | ₹385.00 | ₹426.05 | -10.31% | |
| ₹457.00 | ₹506.85 | ₹430.10 | ₹469.15 | +2.66% | |
| ₹537.00 | ₹553.90 | ₹466.05 | ₹477.05 | -11.16% | |
| ₹625.00 | ₹625.00 | ₹488.15 | ₹542.75 | -13.16% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Kerala Ayurveda Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Kerala Ayurveda Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of KERALAYUR across key market metrics for learning purposes.
Positive Indicators
0 factors identified
No significant strengths identified in current analysis.
Risk Factors
10 factors identified
Below-Average Return on Equity (-99.22%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (-9.01%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (3.52%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Profit Decline Concern (-285.38%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Elevated Debt Levels (D/E: 15.49)
Observation: High leverage increases financial risk and interest burden.
Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.
Weak Interest Coverage (-2.16x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Negative Free Cash Flow (₹-3.75 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 0.03%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
High Share Pledging Risk (23.56%)
Observation: Significant promoter share pledging creates potential overhang.
Analysis: High pledging levels may create selling pressure during market downturns.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Kerala Ayurveda Ltd vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Kerala Ayurveda Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Kerala Ayurveda LtdKerala Ayurveda...Selected✓ KERALAYUR • 530163 | 0/100 | ₹179.15₹179 | ₹437.96₹437.96 | — — | -99.22%Poor -99.22% Poor | -9.01%Poor -9.01% Poor | 15.49Poor 15.5 Poor | — — | 10.35%Good 10.35% Good | 0.00% |
Sun Pharmaceutical Industries LtdSun Pharmaceuti... SUNPHARMA • 524715 | 65.2/100 | ₹1844.30₹1844 | ₹433738.68₹433738.68 | 37.57Average 37.6 Average | 16.86%Good 16.86% Good | 20.21%Excellent 20.21% Excellent | 0.07Excellent 0.1 Excellent | 23.78%Excellent 23.78% Excellent | 9.87%Good 9.87% Good | 0.89% |
Divis Laboratories LtdDivis Laborator... DIVISLAB • 532488 | 67.9/100 | ₹6797.50₹6798 | ₹170445.88₹170445.88 | 68.59Average 68.6 Average | 15.35%Good 15.35% Good | 20.44%Excellent 20.44% Excellent | 0.01Excellent 0.0 Excellent | 10.41%Good 10.41% Good | 11.65%Good 11.65% Good | 0.47% |
Torrent Pharmaceuticals LtdTorrent Pharmac... TORNTPHARM • 500420 | 65.3/100 | ₹4537.80₹4538 | ₹126430.62₹126430.62 | 58.36Average 58.4 Average | 26.52%Excellent 26.52% Excellent | 27.05%Excellent 27.05% Excellent | 0.33Excellent 0.3 Excellent | 13.84%Good 13.84% Good | 7.72%Good 7.72% Good | 0.86% |
Cipla LtdCipla Ltd... CIPLA • 500087 | 59/100 | ₹1418.20₹1418 | ₹123059.76₹123059.76 | 22.62Average 22.6 Average | 17.77%Good 17.77% Good | 22.72%Excellent 22.72% Excellent | 0.01Excellent 0.0 Excellent | 28.68%Excellent 28.68% Excellent | 9.97%Good 9.97% Good | 0.85% |
Dr Reddys Laboratories LtdDr Reddys Labor... DRREDDY • 500124 | 59.2/100 | ₹1319.00₹1319 | ₹105224.96₹105224.96 | 18.23Average 18.2 Average | 17.96%Good 17.96% Good | 22.69%Excellent 22.69% Excellent | 0.16Excellent 0.2 Excellent | 22.28%Excellent 22.28% Excellent | 13.26%Good 13.26% Good | 0.63% |
Lupin LtdLupin Ltd... LUPIN • 500257 | 66.7/100 | ₹2276.40₹2276 | ₹95148.15₹95148.15 | 22.00Average 22.0 Average | 20.62%Excellent 20.62% Excellent | 21.30%Excellent 21.30% Excellent | 0.32Excellent 0.3 Excellent | 54.88%Excellent 54.88% Excellent | 8.11%Good 8.11% Good | 0.58% |
Zydus Lifesciences LtdZydus Lifescien... ZYDUSLIFE • 532321 | 68.7/100 | ₹956.95₹957 | ₹94253.78₹94253.78 | 18.74Average 18.7 Average | 21.21%Excellent 21.21% Excellent | 24.31%Excellent 24.31% Excellent | 0.38Excellent 0.4 Excellent | 25.92%Excellent 25.92% Excellent | 10.27%Good 10.27% Good | 1.17% |
Mankind Pharma LtdMankind Pharma ... MANKIND • 543904 | 50.6/100 | ₹2420.40₹2420 | ₹92012.53₹92012.53 | 52.62Average 52.6 Average | 14.68%Average 14.68% Average | 15.98%Good 15.98% Good | 0.55Good 0.6 Good | 11.73%Good 11.73% Good | 15.79%Excellent 15.79% Excellent | 0.04% |
Aurobindo Pharma LtdAurobindo Pharm... AUROPHARMA • 524804 | 28.8/100 | ₹1435.90₹1436 | ₹70798.69₹70798.69 | 20.69Average 20.7 Average | 11.08%Average 11.08% Average | 14.18%Average 14.18% Average | 0.22Excellent 0.2 Excellent | 3.87%Average 3.87% Average | 6.55%Good 6.55% Good | 0.33% |
Alkem Laboratories LtdAlkem Laborator... ALKEM • 539523 | 59.5/100 | ₹5451.50₹5452 | ₹67075.29₹67075.29 | 28.54Average 28.5 Average | 19.39%Good 19.39% Good | 20.38%Excellent 20.38% Excellent | 0.18Excellent 0.2 Excellent | 13.93%Good 13.93% Good | 9.21%Good 9.21% Good | 0.80% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Ltd share price433738.68 Cr
- Divis Laboratories Ltd share price170445.88 Cr
- Torrent Pharmaceuticals Ltd share price126430.62 Cr
- Cipla Ltd share price123059.76 Cr
- Dr Reddys Laboratories Ltd share price105224.96 Cr
Kerala Ayurveda Ltd Quarterly Performance
Latest quarterly metrics for KERALAYUR — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
14.57%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-285.38%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
10.35%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
Kerala Ayurveda Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for KERALAYUR — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Kerala Ayurveda Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Kerala Ayurveda Ltd (KERALAYUR) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Kerala Ayurveda Ltd
About KERALAYUR (Kerala Ayurveda Ltd)
Kerala Ayurveda Ltd is a pharmaceutical company rooted in the ancient wisdom of Ayurveda, dedicated to crafting authentic and effective health solutions. The company meticulously b...lends traditional Ayurvedic principles with modern scientific advancements to formulate a diverse range of products. These include potent classical medicines meticulously prepared according to time-honored recipes, proprietary formulations developed through rigorous research, and nourishing health supplements. The focus is on providing holistic wellness solutions that address the root cause of imbalances within the body. Kerala Ayurveda Ltd aims to empower individuals to achieve optimal health and vitality through the power of natural healing. The company's product portfolio encompasses a broad spectrum of health and wellness needs. From targeted therapies to address specific ailments, such as pain management and joint care, to comprehensive solutions for overall well-being, Kerala Ayurveda Ltd offers a wide array of options. They cater to the diverse requirements of men, women, and children, offering specialized products for hormonal balance, immune support, and healthy growth. Furthermore, the company understands the impact of lifestyle on health, providing formulations to promote stress relief, cognitive function, and healthy metabolism. The offerings extend beyond internal health, with a line of natural skin, hair, and personal care products that reflect the Ayurvedic philosophy of beauty from within. Kerala Ayurveda Ltd is committed to quality and purity, sourcing the finest herbs and ingredients from sustainable sources. The company adheres to stringent manufacturing standards, ensuring that every product meets the highest levels of efficacy and safety. By combining the ancient knowledge of Ayurveda with modern quality control measures, Kerala Ayurveda Ltd delivers products that are both potent and reliable. The company's unwavering dedication to providing authentic Ayurvedic solutions has made it a trusted name in the pharmaceutical industry.
Company Details
Key Leadership
KERALAYUR Share Price: Frequently Asked Questions
What is the current share price of Kerala Ayurveda Ltd?
Kerala Ayurveda Ltd (KERALAYUR) trades at ₹179.15 on NSE and BSE. Market cap ₹437.96 (Cr). Educational data only.
What is the P/E ratio of Kerala Ayurveda Ltd?
Kerala Ayurveda Ltd has a P/E of N/Ax vs industry average 31.77x.
What is the Bull Run score for Kerala Ayurveda Ltd?
Kerala Ayurveda Ltd has a Bull Run score of 0/100 based on 25+ financial parameters.
Does Kerala Ayurveda Ltd pay dividends?
Kerala Ayurveda Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Kerala Ayurveda Ltd?
Kerala Ayurveda Ltd has ROE of -99.22%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Kerala Ayurveda Ltd?
Kerala Ayurveda Ltd has debt-to-equity of 15.49.
Is Kerala Ayurveda Ltd a good investment?
Bull Run gives Kerala Ayurveda Ltd a score of 0/100. This is not investment advice — consult a SEBI-registered advisor.